“The powers not delegated to the United States by the Constitution, nor prohibited by it to the States, are reserved to the States respectively, or to the people.”
On May 31, the FDA held its first hearing on CBD. After the meeting, the same questions remain as before: will the federal agency continue to maintain its current regulation and prohibition of hemp-derived cannabinoids? Or will it give in to market forces and open the...
